Filing Details
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:TNXP
Tonix Pharmaceuticals Holding Corp. (TNXP) Files Quarterly Report for Q0
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026.
- The company's stock trades at $12.59 with a market capitalization of $172.1 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Tonix Pharmaceuticals Holding Corp.'s stock currently trades at $12.59 with a market capitalization of $172.1M.
The 10-Q provides Tonix Pharmaceuticals Holding Corp.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Tonix Pharmaceuticals Holding Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TNXP Stock Page
Frequently Asked Questions
Where can I read TNXP's SEC filings?
Browse all filings on our TNXP SEC filings page.
What types of SEC filings does Tonix Pharmaceuticals Holding Corp. file?
Public companies like Tonix Pharmaceuticals Holding Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.